Skip to main content

Table 1 Outcomes of patients treated for biliary strictures after LDLT (N = 16)

From: Endoscopic stent placement above the sphincter of Oddi for biliary strictures after living donor liver transplantation

Patienta

(age/sex)

Indications

For transplant

Graft

Stricture morphology

Tip shape of the distal duct

ERCP

(No)

Endoscopic

Treatment Success

Number of strictures

Inside Stent

(times)

Outside Stent (times)

Stent indwelling period (months)

Follow Up period (months)

Present status

30–39/sex 1

Fulminant liver failure

Left

Non-visualization

Round

1

No

1

0

0

0

108

Choledochojejunostomy

30–39/sex 2

Fulminant liver failure

Left

Wide

Tapered

14

Yes

1

11

1

105

105

Inside stent

50–59/sex 2

LC-PBC

Left

Separate

Round

8

Yes

1

8

0

85

85

Inside stent

60–69/sex 2

LC-HBV

Left

Narrow

Tapered

7

Yes

1

7

0

42

56

Stricture resolution

50–59/sex 1

LC-HCV

Left

Narrow

Tapered

5

Yes

1

3

0

19

35

Stricture resolution

60–69/sex 1

LC-HCV

Left

Narrow

Tapered

5

Yes

1

3

1

23

23

Inside stent

60–69/sex 2

LC-PBC

Left

Narrow

Round

3

Yes

1

3

0

16

16

Inside stent

50–59/sex 1

LC-HBV

Right

Narrow

Tapered

7

Yes

1

5

2

58

127

Stricture resolution

40–49/sex 1

LC-HBV

Right

Non-visualization

Round

1

No

2

0

0

0

124

Choledochojejunostomy

50–59/sex 1

LC-HCV

Right

Narrow

Tapered

8

Yes

2

5

2

17

93

Stricture resolution

40–49/sex 1

LC-NASH

Right

Separate

Round

6

Yes

2

6

0

84

84

Inside stent

60–69/sex 1

LC-alcohol

Right

Separate

Tapered

5

Yes

2

3

1

70

78

Stricture resolution

50–59/sex 1

LC-alcohol

Right

Separate

Tapered

6

Yes

1

6

0

61

61

Inside stent

60–69/sex 2

LC-HCV

Right

Separate

Tapered

4

Yes

1

4

0

19

52

Stricture resolution

50–59/sex 2

LC-PBC

Right

Narrow

Tapered

6

Yes

2

3

3

27

45

Stricture resolution

60–69/sex 1

LC-HCV

Posterior

Separate

Round

12

Yes

1

12

0

87

87

Inside stent

  1. LDLT Living donor liver transplantation, LC-PBC Liver cirrhosis secondary to primary biliary cholangitis, HBV Hepatitis B virus, HCV Hepatitis C virus, NASH Non-alcoholic steatohepatitis
  2. a Age and sex of the patients are not specified to anonymize the data